Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Azilect® In Wearing-Off (AIWO) Non-interventional Study on Efficacy and Tolerability of Rasagiline (1mg/d) add-on in Ambulatory Parkinson's Disease Patients With Wearing-off Symptoms Diagnosed by Wearing-off Questionnaire (WOQ-32)

NCT02384512 is registered in ClinicalTrials.gov with Teva Pharma GmbH as lead sponsor.

NCT NCT02384512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02384512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Azilect® In Wearing-Off (AIWO) Non-interventional Study on Efficacy and Tolerability of Rasagiline (1mg/d) add-on in Ambulatory Parkinson's Disease Patients With Wearing-off Symptoms Diagnosed by Wearing-off Questionnaire (WOQ-32)
Lead sponsor
Teva Pharma GmbH
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
January 31, 2015
Enrollment
261 (actual)
Sites
140

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease